论文部分内容阅读
目的观察自拟消症抗癌方联合化疗治疗中晚期宫颈癌的临床疗效。方法将中晚期宫颈癌患者206例随机分为试验组和对照组各103例。试验组给予自拟消症抗癌方联合化疗治疗,对照组仅给予化疗治疗,比较2组的临床疗效。结果试验组治疗后Ⅱb期例数高于对照组,而Ⅲ期例数低于对照组,差异均有统计学意义(P<0.05);而2组患者治疗后Ⅳ期例数相近,差异均无统计学意义(P>0.05)。治疗后2组患者血流量及血容量均低治疗前,且试验组低于对照组,差异均有统计学意义(P<0.05)。结论自拟消症抗癌方联合化疗治疗中晚期宫颈癌患者临床分期及病变血流量和血容量均显著降低。
Objective To observe the curative effect of self-designed anti-cancer anti-cancer combined with chemotherapy in the treatment of advanced cervical cancer. Methods 206 patients with advanced cervical cancer were randomly divided into experimental group and control group of 103 cases. The experimental group given self-destructive anti-cancer chemotherapy combined with chemotherapy, the control group was given only chemotherapy, the clinical efficacy of the two groups were compared. Results The number of cases in trial group Ⅱb after treatment was higher than that in control group, while the number of cases in stage Ⅲ was lower than that in control group (P <0.05); while the number of cases in stage Ⅱ after treatment was similar in both groups No statistical significance (P> 0.05). After treatment, blood flow and blood volume were lower in the two groups before treatment, and the experimental group was lower than the control group, the difference was statistically significant (P <0.05). Conclusions Self-destructive anti-cancer combined with chemotherapy in the treatment of advanced cervical cancer clinical stage and lesion blood flow and blood volume were significantly lower.